Agenus (Formerly known as Antigenics Inc. - Lexington, MA) to Present at Biotechnology Industry Organization (BIO) CEO & Investor Conference

LEXINGTON, Mass., Feb. 6, 2012 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a developer of therapeutic vaccines for cancer and infectious diseases, today announced that the company will be presenting at the 14th Annual BIO CEO & Investor Conference, which will be held at the Waldorf=Astoria Hotel in New York City.